Trial Profile
A Multi-centre Randomised Study of Induction Chemotherapy Followed by Capecitabine (+/-Nelfinavir) With High or Standard Dose Radiotherapy for Locally Advanced Non-metastatic Pancreatic Cancer
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 23 Oct 2023
Price :
$35
*
At a glance
- Drugs Nelfinavir (Primary) ; Capecitabine; Gemcitabine; Paclitaxel
- Indications Carcinoma; Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms SCALOP-2
- 01 Jun 2021 Status changed from active, no longer recruiting to completed.
- 10 Jun 2020 Status changed from suspended to active, no longer recruiting.
- 10 Jun 2020 Planned End Date changed from 1 Aug 2020 to 31 May 2021.